NO982414L - Ny kombinasjon - Google Patents

Ny kombinasjon

Info

Publication number
NO982414L
NO982414L NO982414A NO982414A NO982414L NO 982414 L NO982414 L NO 982414L NO 982414 A NO982414 A NO 982414A NO 982414 A NO982414 A NO 982414A NO 982414 L NO982414 L NO 982414L
Authority
NO
Norway
Prior art keywords
active ingredient
new combination
kit
formoterol
budesonide
Prior art date
Application number
NO982414A
Other languages
English (en)
Other versions
NO982414D0 (no
Inventor
Jan Trofast
Anders Ullman
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO982414D0 publication Critical patent/NO982414D0/no
Publication of NO982414L publication Critical patent/NO982414L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Preparat eller kit som, som en første aktive bestanddel har formoterol eller et salt eller solvat derav, og som en annen aktiv bestanddel har budesonid, hvor molarforholdet for den første aktive bestanddelen til den andre aktive bestanddelen er fra i :30 til l :36. Anvendelsen av nevnte preparat og kit i behandlingen av åndedrettsforstyrrelser er også beskrevet.
NO982414A 1996-10-08 1998-05-27 Ny kombinasjon NO982414L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9603669A SE9603669D0 (sv) 1996-10-08 1996-10-08 New combination
PCT/SE1997/001606 WO1998015280A1 (en) 1996-10-08 1997-09-24 New combination

Publications (2)

Publication Number Publication Date
NO982414D0 NO982414D0 (no) 1998-05-27
NO982414L true NO982414L (no) 1998-05-27

Family

ID=20404167

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982414A NO982414L (no) 1996-10-08 1998-05-27 Ny kombinasjon

Country Status (18)

Country Link
EP (1) EP0871450A1 (no)
JP (1) JP2000502365A (no)
KR (1) KR19990071975A (no)
AR (1) AR013614A1 (no)
AU (1) AU715319B2 (no)
BR (1) BR9706822A (no)
CA (1) CA2239308A1 (no)
CZ (1) CZ176198A3 (no)
HU (1) HUP9901674A3 (no)
MY (1) MY128337A (no)
NO (1) NO982414L (no)
NZ (1) NZ330482A (no)
PL (1) PL327037A1 (no)
SE (1) SE9603669D0 (no)
SK (1) SK75198A3 (no)
TW (1) TW470647B (no)
WO (1) WO1998015280A1 (no)
ZA (1) ZA978889B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9700134D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700136D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
JP2002510310A (ja) * 1997-06-27 2002-04-02 アストラ・アクチエボラーグ 抗喘息薬の新規配合
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
SE9900834D0 (sv) * 1999-03-09 1999-03-09 Astra Ab Novel combination
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
FI20002216A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
SE527069C2 (sv) 2003-06-19 2005-12-13 Mederio Ag Förfarande och anordning för administrering av läkemedelspulver
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050026887A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
WO2008000042A1 (en) 2006-06-30 2008-01-03 Iceutica Pty Ltd Methods for the preparation of biologically active compounds in nanoparticulate form
JP2010519195A (ja) 2007-02-19 2010-06-03 シプラ・リミテッド 薬学的組成物
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
SI3111927T1 (sl) 2009-05-29 2020-08-31 Pearl Therapeutics, Inc. Sestavki za respiratorni vnos aktivnih učinkovin in s tem povezani postopki in sistemi
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
JP6285866B2 (ja) 2011-11-23 2018-02-28 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然複合ホルモン補充製剤および療法
CN104703584B (zh) * 2012-02-28 2019-05-31 艾塞尤提卡控股公司 可吸入药物组合物
ITMI20130571A1 (it) 2013-04-10 2014-10-11 Zambon Spa Composizione farmaceutica contenente budesonide e formoterolo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE213946T1 (de) * 1991-12-18 2002-03-15 Formoterol und budesonide enthaltende zusammensetzung

Also Published As

Publication number Publication date
WO1998015280A1 (en) 1998-04-16
HUP9901674A3 (en) 2001-04-28
NZ330482A (en) 1999-11-29
ZA978889B (en) 1998-04-08
HUP9901674A2 (hu) 1999-09-28
MY128337A (en) 2007-01-31
BR9706822A (pt) 1999-03-23
JP2000502365A (ja) 2000-02-29
CZ176198A3 (cs) 1998-09-16
KR19990071975A (ko) 1999-09-27
SK75198A3 (en) 1998-11-04
AU4578297A (en) 1998-05-05
CA2239308A1 (en) 1998-04-16
AR013614A1 (es) 2001-01-10
EP0871450A1 (en) 1998-10-21
AU715319B2 (en) 2000-01-20
PL327037A1 (en) 1998-11-09
NO982414D0 (no) 1998-05-27
TW470647B (en) 2002-01-01
SE9603669D0 (sv) 1996-10-08

Similar Documents

Publication Publication Date Title
NO982414L (no) Ny kombinasjon
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
NO950774L (no) Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol
IS2788B (is) Búdesóníð- / formóterólefnablanda til innöndunar með lausa þéttni frá 0,30 til 0,36 g/ml, aðferð við að framleiða efnablönduna og notkun hennar
ES2182357T3 (es) Nueva utilizacion de budesonide y formoterol.
SE9802073D0 (sv) New use
TR200003158T2 (tr) Jelleşebilen farmasötik bileşimler
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
NO20080284L (no) Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
NO20012977D0 (no) N-ureidoalkylpiperidiner som modulatorer av chemokinreseptoraktivitet
FI953515A (fi) Fluoksetiinin farmaseuttiset formulaatiot
BR0211119A (pt) Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto
NO951498L (no) Farmasöytisk preparat for behandling av osteoporose
NO20010833L (no) Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler
IS2789B (is) Lyfjablöndur sem innihalda mónóamínoxídasa B hemla
CA2136404A1 (fr) Composition solide mucoadhesive, therapeutique ou hygienique, pour administration par application sur la muqueuse buccale ou nasale
UY24308A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol, para administracion oral
HUP9901686A2 (hu) Fungicid keverékek
NO982989L (no) Anvendelse av inhibitorer av den cellulµre Na+/H+-utbytteren (NHE) for fremstilling av et medikament for respiratorstimulering
DE50109650D1 (de) Topische behandlung bei der mastalgie
JPH0755895B2 (ja) 歯磨組成物
EP1284265A4 (en) BENZOTHIOPHENE DERIVATIVES AND MEDICINAL USE THEREOF
CA2152998A1 (en) Anti-hyperglycemia pharmaceutical composition
TR199700963T1 (xx) Kardiyovask�ler hastal�klar�n tedavisi i�in aminotetralin t�revi.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application